129 related articles for article (PubMed ID: 15779107)
1. Use of hormonal replacement therapy after treatment of breast cancer. Number 142, May 2004.
SOGC
Int J Gynaecol Obstet; 2005 Feb; 88(2):216-21. PubMed ID: 15779107
[TBL] [Abstract][Full Text] [Related]
2. Use of hormonal replacement therapy after treatment of breast cancer.
Lea R; Bannister E; Case A; Levesque P; Miller D; Provencher D; Rosolovich V;
J Obstet Gynaecol Can; 2004 Jan; 26(1):49-60; quiz 62-4. PubMed ID: 14715126
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer, pregnancy, and breastfeeding.
Helewa M; Lévesque P; Provencher D; Lea RH; Rosolowich V; Shapiro HM;
J Obstet Gynaecol Can; 2002 Feb; 24(2):164-80; quiz 181-4. PubMed ID: 12196882
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the number of embryos to transfer following in vitro fertilization No. 182, September 2006.
JOINT SOGC-CFAS
Int J Gynaecol Obstet; 2008 Aug; 102(2):203-16. PubMed ID: 18773532
[TBL] [Abstract][Full Text] [Related]
5. Vaginal delivery of breech presentation.
Kotaska A; Menticoglou S; Gagnon R;
J Obstet Gynaecol Can; 2009 Jun; 31(6):557-566. PubMed ID: 19646324
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?
Roy JA; Sawka CA; Pritchard KI
J Clin Oncol; 1996 Mar; 14(3):997-1006. PubMed ID: 8622051
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer in premenopausal women: recurrence and survival rates and relationship to hormone replacement therapy.
Durna EM; Heller GZ; Leader LR; Sjoblom P; Eden JA; Wren BG
Climacteric; 2004 Sep; 7(3):284-91. PubMed ID: 15669553
[TBL] [Abstract][Full Text] [Related]
8. SOGC clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004.
Society of Obstetricians and Gynaecologists of Canada
Int J Gynaecol Obstet; 2005 Feb; 88(2):222-8. PubMed ID: 15779109
[TBL] [Abstract][Full Text] [Related]
9. The management of uterine leiomyomas.
Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic therapy in preterm premature rupture of the membranes.
Yudin MH; van Schalkwyk J; Eyk NV; ;
J Obstet Gynaecol Can; 2009 Sep; 31(9):863-867. PubMed ID: 19941711
[TBL] [Abstract][Full Text] [Related]
11. SOGC clinical guidelines. Hysterectomy.
Lefebvre G; Allaire C; Jeffrey J; Vilos G; Arneja J; Birch C; Fortier M;
J Obstet Gynaecol Can; 2002 Jan; 24(1):37-61; quiz 74-6. PubMed ID: 12196887
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and breast cancer morbidity, mortality and recurrence.
Kenemans P; Scheele F; Burger CW
Eur J Obstet Gynecol Reprod Biol; 1997 Feb; 71(2):199-203. PubMed ID: 9138966
[TBL] [Abstract][Full Text] [Related]
13. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
Temple LK; Wang EE; McLeod RS
CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prenatally diagnosed structural congenital anomalies.
Gagnon A;
J Obstet Gynaecol Can; 2009 Sep; 31(9):875-881. PubMed ID: 19941713
[TBL] [Abstract][Full Text] [Related]
15. Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer.
Ringash J;
CMAJ; 2001 Feb; 164(4):469-76. PubMed ID: 11233866
[TBL] [Abstract][Full Text] [Related]
16. Exercise in pregnancy and the postpartum period.
Davies GA; Wolfe LA; Mottola MF; MacKinnon C; Arsenault MY; Bartellas E; Cargill Y; Gleason T; Iglesias S; Klein M; Martel MJ; Roggensack A; Wilson K; Gardiner P; Graham T; Haennel R; Hughson R; MacDougall D; McDermott J; Ross R; Tiidus P; Trudeau F;
J Obstet Gynaecol Can; 2003 Jun; 25(6):516-29. PubMed ID: 12806453
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.
Pritchard KI; Khan H; Levine M;
CMAJ; 2002 Apr; 166(8):1017-22. PubMed ID: 12002977
[TBL] [Abstract][Full Text] [Related]
19. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone replacement therapy: effect on diagnosis and outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Fowble B; Hanlon A; Freedman G; Patchefsky A; Kessler H; Nicolaou N; Hoffman J; Sigurdson E; Boraas M; Goldstein L
J Clin Oncol; 1999 Jun; 17(6):1680-8. PubMed ID: 10561204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
